Drugs / gramicidin
last change Jan 2011 re-read 2 minutes ago

gramicidin

Developed for
bacterial infectious disease with sepsis · hordeolum · skin infection
Investigated by
Chulalongkorn University · Fraser Health

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) NEOSPORIN 1968-07-03 fda.gov

Trials 2 · a red edge is where a trial was stopped

19671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT00534391 Sep 2007 → Dec 2008 hordeolum Chulalongkorn University Unknown No outcome recorded
Phase not applicable1 trial
NCT00990392 Nov 2009 → Jan 2011 bacterial infectious disease with sepsis, skin infection Fraser Health Withdrawn No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as gramicidin “Polysporin Triple Therapy (gramicidin, polymixin, bacitracin)” NCT00990392
1

NCT00534391

Known as Gramicidin component of neo-polycin ChEMBL registry synonym — accepted as the source's own label CHEMBL1201469
Known as Gramicidin d ChEMBL registry synonym — accepted as the source's own label CHEMBL1201469
Known as Gramicidina ChEMBL registry synonym — accepted as the source's own label CHEMBL1201469
Known as Gramicidine ChEMBL registry synonym — accepted as the source's own label CHEMBL1201469
Known as NSC-757043 ChEMBL registry synonym — accepted as the source's own label CHEMBL1201469
Route Topical “to the effected eye” NCT00534391